STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Completed
- Recurrent/Refractory Lymphoma
- Mitoxantrone Hydrochloride Liposome Injection
- Guiyang, Guizhou, ChinaGuizhou Cancer Hospita
2021-12-12
Dec 12, 2021C
Recruiting
- Relapsed or Refractory Multiple Myeloma
- Mitoxantrone Hydrochloride Liposome injection
- +2 more
- Beijing, Beijing, ChinaBeijing Chaoyang Hospital, Capital Medical University
2022-01-16
Jan 16, 2022C
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
Not yet recruiting
- Advanced Pancreatic Cancer
- Mitoxantrone Hydrochloride Liposome injection
- (no location specified)
2021-10-19
Oct 19, 2021C
Not yet recruiting
- Advanced Malignant Tumor
- Mitoxantrone Hydrochloride Liposome
- (no location specified)
2021-10-09
Oct 9, 2021C
Recruiting
- Treatment-naïve
- Peripheral T Cell Lymphoma
- Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
- Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
- Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
2021-07-26
Jul 26, 2021C
Not yet recruiting
- Advanced Solid Tumors
- Mitoxantrone Hydrochloride Liposome injection
- Baoding, Hebei, ChinaAffiliated Hospital of Hebei University
2021-06-04
Jun 4, 2021I
Not yet recruiting
- Non Hodgkin Lymphoma
- Liposomal Mitoxantrone Hydrochloride dose level 1
- +6 more
- (no location specified)
2022-03-17
Mar 17, 2022C
Not yet recruiting
- Recurrent Head and Neck Cancer
- Metastatic Head and Neck Cancer
- Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
- (no location specified)
2021-05-20
May 20, 2021C
Not yet recruiting
- Unresectable or Metastatic Bone and Soft Tissue Sarcoma
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
2021-05-20
May 20, 2021C
Not yet recruiting
- Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Mitoxantrone Hydrochloride liposome injection
- Cytarabine (LoDAC)
- Guiyang, Guizhou, ChinaThe Affiliated Hospital of Guizhou Medical University
2021-10-19
Oct 19, 2021N
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Clofarabine
- Mitoxantrone
- Valhalla, New York
- +1 more
2021-10-29
Oct 29, 2021W
Active, not recruiting
- Granulocytic Sarcoma
- Recurrent Adult Acute Myeloid Leukemia
- 6,8-Bis(benzylthio)octanoic Acid
- +3 more
- Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
2022-01-03
Jan 3, 2022C
Not yet recruiting
- Peripheral T Cell Lymphoma
- Mitoxantrone Hydrochloride Liposome Injection
- Chidamide
- Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
2020-12-11
Dec 11, 2020C
Active, not recruiting
- Advanced Solid Tumor
- Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
- Bengbu, Anhui, China
- +7 more
2021-10-28
Oct 28, 2021F
Active, not recruiting
- Acute Myeloid Leukemia
- Cladribine
- +5 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2021-07-06
Jul 6, 2021C
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer
Recruiting
- Platinum-resistant Ovarian Cancer
- Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
- Chongqing, Chongqing, China
- +6 more
2021-05-31
May 31, 2021C
Not yet recruiting
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase
- +2 more
- (no location specified)
2020-08-09
Aug 9, 2020S
Completed
- Neuromyelitis Optica
- +3 more
- Mitoxantrone
- Buffalo, New YorkBaird Multiple Sclerosis Center
2020-12-23
Dec 23, 2020C
Recruiting
- Advanced Gastric Carcinoma
- Mitoxantrone Hydrochloride Liposome, intravenous injection
- Beijing, Beijing, China
- +8 more
2021-05-31
May 31, 2021U
Active, not recruiting
- Acute Biphenotypic Leukemia
- +4 more
- Cladribine
- +6 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-02-07
Feb 7, 2022U
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-02-23
Feb 23, 2022T
Recruiting
- Relapsed Adult AML
- Venetoclax Oral Tablet
- Dresden, Germany
- +5 more
2021-09-06
Sep 6, 2021C
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Liposome-entrapped Mitoxantrone Hydrochloride Injection
- (no location specified)
2021-06-14
Jun 14, 2021P
Recruiting
- AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
- MRD-triggered arm
- Prophylactic Arm
- Heidelberg, BW, GermanyUniversity Hospital Heidelberg Med5
2021-01-04
Jan 4, 2021I
Completed
- Multiple Sclerosis
- plasmapheresis
- Isfahan, Iran, Islamic Republic ofAlahra hospital
2020-08-27
Aug 27, 2020